-Advertisement-
-Advertisement-
Trending Topics
FDA grants accelerated approval for early Alzheimer’s drug
The U.S. Food and Drug Administration has approved Leqembi (lecanemab-irmb) for the treatment of Alzheimer’s disease, according to a press release. Approval was granted via the Accelerated Approval pathway based on results from the phase 3 randomized, controlled clinical trial which confirmed the clinical benefit of lecanemab. In the double-blind,...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
Videos
-Advertisement-
Contact
© 2025 Med Journal 360® is a trademark of International Healthcare Media, LLC. All rights Reserved